ISP Pharmaceuticals is expanding its R&D facilities in Hyderabad by setting up a 'Solubility Center of Excellence' as part of its drug solubility initiative. The facilities in Hyderabad will act as a focal point for the R&D ISP conducts in the area of solubilisation of drug actives for the pharmaceutical industry. Activities at the new centre will focus on the use of polymers, disintegrants and cyclodextrin chemistry as tools to achieve improved drug solubility and bioavailability in oral and parenteral pharmaceuticals.
展开▼
